Premium
Fixed drug eruption with interferon‐β‐1b
Author(s) -
Tai Yee J,
Tam Mei
Publication year - 2005
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/j.1440-0960.2005.00168.x
Subject(s) - drug eruption , medicine , histopathology , drug , dermatology , biopsy , rash , drug reaction , skin biopsy , adverse drug reaction , surgery , pathology , pharmacology
SUMMARY A 32‐year‐old woman with multiple sclerosis who developed non‐injection‐site‐related fixed drug eruption with interferon‐β‐1b. Erythematous plaques started appearing 1 month after the drug was introduced, and increased in number following each administration. The histopathology of a skin biopsy was consistent with fixed drug eruption. The drug was subsequently ceased, with resolution of the rash 6 weeks later.